[1
]
From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School,
Boston (S.D.S., M.A.P., A.S.D., B.C.); the British Heart Foundation Cardiovascular
Research Centre (J.J.V.M., P.S.J.) and the Robertson Centre for Biostatistics and
Clinical Trials, Institute of Health and Well-being (J.C.), University of Glasgow,
Glasgow, and the National Heart and Lung Institute, Royal Brompton and Harefield Hospitals,
Imperial College, London (J.C.) - all in the United Kingdom; University of Minnesota,
Minneapolis (I.S.A), and Mayo Clinic, Rochester (M.M.R.) - both in Minnesota; Shanghai
Institute of Cardiovascular Diseases (J. Ge) and the Department of Cardiology (J.Z.),
Zhongshan Hospital, Fudan University, Shanghai, China; National Heart Center Singapore
and Duke-National University of Singapore, Singapore (C.S.P.L); National Association
of Hospital Cardiologists Research Center, Florence (A.P.M.), and the Cardiology Division,
Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo (M.S.) - both in
Italy; National University of Cordoba, Cordoba, Argentina (F.M.); Baylor University
Medical Center, Dallas (M.P.); the Department of Internal Medicine and Cardiology,
German Center for Cardiovascular Research partner site Berlin (B.P.), and the Department
of Cardiology, Charité Universitätsmedizin, Campus Virchow-Klinikum (H.-D.D.) - both
in Berlin; Institut de Cardiologie de Montréal, Université de Montréal, Montreal (J.L.R.);
the Department of Cardiology, University Medical Center Groningen, University of Groningen,
Groningen, the Netherlands (D.J.V.); INSERM Centre d'Investigation Clinic 1433 and
Université de Lorraine, Centre Hospitalier Régional et Universitaire, Nancy, France
(F.Z.); Medical University of South Carolina and the Ralph H. Johnson Department of
Veterans Affairs Medical Center, Charleston (M.R.Z.); National Research Center for
Cardiology of the Ministry of Health of the Russian Federation, Moscow (S.A.B.); Community
Heart Failure Program, Department of Cardiology, Bellvitge University Hospital and
Bellvitge Institute for Biomedical Research, University of Barcelona, Barcelona (J.C.-C.);
Department of Heart Failure-Transplantation, National Cardiovascular Institute, Bratislava,
Slovakia (E.G.); Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria
(T.K.); Disciplina de Cardiologia Faculdade de Medicina Pontifícia Universidade Católica
de Campinas, São Paulo (J.F.K.S.); the Department of Noninvasive Cardiology, Medical
University of Lodz, Lodz, Poland (M.L.); Heart and Vascular Center, Semmelweis University,
Budapest, Hungary (B.M.); Division of Cardiology, Department of Medicine, Northwestern
University Feinberg School of Medicine, Chicago (S.J.S); and Novartis Pharmaceuticals,
East Hanover, NJ (A.R.R., J. Gong, V.C.S., M.P.L.).